Navigation Links
Cell Therapeutics Reports Second Quarter 2013 Financial Results
Date:7/31/2013

omparator therapies assigned by the G-BA under Germany's AMNOG law.  The determination reflected the absence of a comparator under AMNOG law specifically for this stage of aggressive NHL because prior to the approval of PIXUVRI in the European Union (E.U.), there was no therapy specifically approved for this stage of disease. The G-BA also decided that the prescribability for PIXUVRI should be limited to hematologists and oncologists. CTI is currently negotiating pricing with the GKV-SV, the Federal Association of Statutory Health Insurance Funds.

Research and Development:  New Data Presentation on Pacritinib's Safety Profile

  • Reported results from pooled integrated safety analysis from four Phase 1 and 2 clinical studies that demonstrated the safety, tolerability and persistence of pacritinib, CTI's novel, oral JAK2/FLT3 inhibitor, in patients with myelofibrosis at the European Hematology Association Congress.
  • Reported on the publication of a comprehensive article summarizing preclinical and clinical data for pacritinib, authored by Srdan Verstovsek, M.D., Ph.D., et al., in the journal Drugs of the Future 2013.
  • Corporate:  Added to Russell Indices and Established Leadership for SAB

  • Added to Russell Investments' Russell 3000® and Russell Global indices.
  • Named distinguished cancer investigator, Daniel Von Hoff, M.D., F.A.C.P., as Chairman and to lead formation of CTI's Scientific Advisory Board (SAB).
  • Second Quarter 2013 Financial ResultsTotal revenues for the second quarter and the six months ended June 30, 2013 were $0.3 million and $1.4 million, respectively.  The revenues were solely attributable to net product sales of PIXUVRI.  CTI sells PIXUVRI directly to health care providers and through a limited number of wholesale distributors in the E.U.  CTI records product sales upon receipt of the product by the health care provider or distributor, n
    '/>"/>

    SOURCE Cell Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
    7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... 22, 2014 Research ... addition of the  "Global Operating Room Equipment ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An operating ... environment in a healthcare facility used to ... technically advanced equipment, which ensures patient care ...
    (Date:8/22/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... in the 2014 Innovations in Specialty Pharmacy Competition, ... of the competition were announced in the August ... Diplomat was honored as a Top Innovator ... Through Diplomat University, the company has implemented a ...
    (Date:8/22/2014)... , Aug. 22, 2014 /CNW/ - On Aug. 20, ... , the Canadian Medical Association (CMA) voted on and ... plant material, including medicinal cannabis. Bedrocan Cannabis Corp., a ... of the CMA motion. The CMA is ... hazards associated with smoking any plant material, including medicinal ...
    Breaking Medicine Technology:Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2
    (Date:8/22/2014)... complex autoimmune disease that affects 1 to 2 ... cope with pain, disability and joint disfigurements, but ... life and marital functioning. While many pharmacological advances ... is common. In addition, some patients avoid newer ... effects. Because of this, there is interest in ...
    (Date:8/22/2014)... Eagerly embracing intended parents around the globe, ... offers the top male infertility programs — run by ... network of IVFinMexico.com continues to shape modern ... female and male infertility, advanced research and education. , ... eminently set by company CEO and Founder Tolga Umar ...
    (Date:8/22/2014)... time provides an opportunity for parents to develop an ... expert suggests. "Forget New Year,s resolutions; the start ... start of a new fitness and exercise program for ... University of the Sciences in Philadelphia, said in a ... to build up, "it,s important for mom and dad ...
    (Date:8/22/2014)... again attained the distinguished Magnet hospital designation by ... Program. Considered the gold standard for nursing excellence, ... and professionalism. It is the top international credential ... redesignate Newport Hospital was based on the hospital,s ... practice. , "It is a privilege for us ...
    (Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
    Breaking Medicine News(10 mins):Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:With Kids in School, Parents Can Work Out 2Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2
    ... Rochelle, NY, November 1, 2011Clinicians often face the challenge ... parents, teachers, and children about a child,s behavioral problems. ... of these disagreements may provide important information that could ... the current issue of Journal of Child and ...
    ... take aspirin for a headache, thank a willow tree. ... found in willow tree bark and is made by ... mimicking the chemical production processes of plants, scientists have ... alkaloid drug products, including caffeine, atropine (an anti-spasmodic used ...
    ... million expanded initiative sponsored by the National Institutes of ... cardiovascular disease and to assess potential new treatments in ... Americans have diabetes, the seventh leading cause of death ... of heart disease, stroke, kidney disease, blindness and amputation. ...
    ... undergoing percutaneous coronary intervention (PCI), also known as ... than men. Risk-adjusted analyses have now indicated that, ... independent mortality predictor following PCI according to the ... Interventions , a journal published by Wiley-Blackwell on ...
    ... recent study published in the November issue of the ... many radiologists disagree on the management of incidental findings ... finding is something found that is unrelated to the ... in CT resolution have improved radiologists, ability to identify ...
    ... of a study being published online Oct. 31, 2011, in the ... women who carry mutations in a BRCA gene - but who ... an increased risk of developing breast cancer compared to relatives of ... results run counter to a previous study showing a higher risk ...
    Cached Medicine News:Health News:Conflicting views of a child's behavior problems from parents, teachers, and the child may be helpful to clinician 2Health News:Plant researchers locate transporter used for nicotine metabolism 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 3Health News:Women undergoing PCI display greater number of co-morbidities than men 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 3
    DRUGology is a source designed for primary care health providers, residents and medical students so that they may have a quick reference to treat a wide variety of conditions....
    AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more....
    ... combination of new measuring principle - Pupil ... - SLD - offers high accuracy and ... ARK-530A/510A provides ordinary measurement (3.3 mm) using ... (6 mm) using 4 points, both of ...
    ... Sorting System RSD 800 is an individually ... (additional tube type identification via cap recognition ... various sample tubes in a clearly organized ... are customized and offer high capacity. The ...
    Medicine Products: